论文部分内容阅读
非小细胞肺癌约占所有肺癌的80%,预后差,5年生存率仅为13%,而70%的患者确诊时已为中、晚期,失去手术机会或不愿接受手术。支气管动脉灌注化疗加栓塞对非小细胞肺癌是行之有效的治疗方案,但是由于支气管动脉变异较多,化疗方案不甚完善,致使单纯一种介入治疗有不足之处。近年,放射性粒子植入治疗恶性肿瘤逐步应
Non-small cell lung cancer accounts for about 80% of all lung cancers. The prognosis is poor, and the 5-year survival rate is only 13%. However, 70% of patients have been diagnosed mid-late and lost the chance of surgery or are unwilling to undergo surgery. Bronchial artery infusion chemotherapy plus embolization is an effective treatment for non-small cell lung cancer, but because of the variability of the bronchial artery, the chemotherapy regimen is not perfect, resulting in a simple interventional treatment has shortcomings. In recent years, radioactive seed implantation for malignant tumors should gradually